UroGen Pharma Ltd. URGN
| Analyst |
Entreprise |
Price during analysis |
Target price |
Potential gain |
Publication date |
| Paul Choi |
Goldman Sachs |
12.03 $ |
16 $ |
3.97 % |
14/06/2025 |
| Leland Gershell |
Oppenheimer |
12.03 $ |
31 $ |
18.97 % |
13/06/2025 |
| Jason Kolbert |
EF Hutton |
12.6 $ |
25 $ |
12.40 % |
14/10/2024 |
| Stephen Richardson |
Evercore ISI |
20.26 $ |
46 $ |
25.74 % |
14/06/2024 |
| Leland Gershell |
Oppenheimer |
17.5 $ |
40 $ |
22.50 % |
14/06/2024 |
| Raghuram Selvaraju |
H.C. Wainwright |
17.5 $ |
60 $ |
42.50 % |
14/06/2024 |
| Paul Choi |
Goldman Sachs |
17.5 $ |
22 $ |
4.50 % |
14/06/2024 |
| Leland Gershell |
Oppenheimer |
13.07 $ |
32 $ |
18.93 % |
14/05/2024 |
| Leland Gershell |
Oppenheimer |
14.46 $ |
34 $ |
19.54 % |
15/03/2024 |